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License 4.0 (CC BY-NC).Improved base excision repair inhibition and
bacteriophage Mu Gam protein yields C:G-to-T:A base
editors with higher efficiency and product purity
Alexis C. Komor,1,2,3* Kevin T. Zhao,1,2,3 Michael S. Packer,1,2,3† Nicole M. Gaudelli,1,2,3
Amanda L. Waterbury,1 Luke W. Koblan,1,2,3 Y. Bill Kim,1,2,3 Ahmed H. Badran,1,2,3 David R. Liu1,2,3‡We recently developed base editing, the programmable conversion of target C:G base pairs to T:A without
inducing double-stranded DNA breaks (DSBs) or requiring homology-directed repair using engineered fusions
of Cas9 variants and cytidine deaminases. Over the past year, the third-generation base editor (BE3) and related
technologies have been successfully used by many researchers in a wide range of organisms. The product
distribution of base editing—the frequency with which the target C:G is converted to mixtures of undesired
by-products, along with the desired T:A product—varies in a target site–dependent manner. We characterize
determinants of base editing outcomes in human cells and establish that the formation of undesired products is
dependent on uracil N-glycosylase (UNG) and is more likely to occur at target sites containing only a single C
within the base editing activity window. We engineered CDA1-BE3 and AID-BE3, which use cytidine deaminase
homologs that increase base editing efficiency for some sequences. On the basis of these observations, we
engineered fourth-generation base editors (BE4 and SaBE4) that increase the efficiency of C:G to T:A base
editing by approximately 50%, while halving the frequency of undesired by-products compared to BE3.
Fusing BE3, BE4, SaBE3, or SaBE4 to Gam, a bacteriophage Mu protein that binds DSBs greatly reduces indel
formation during base editing, in most cases to below 1.5%, and further improves product purity. BE4, SaBE4,
BE4-Gam, and SaBE4-Gam represent the state of the art in C:G-to-T:A base editing, and we recommend their use
in future efforts.INTRODUCTION
Traditional genome editing methods introduce a double-stranded
DNA break (DSB) at a genomic target locus (1). The cellular response
to a DSB lesion primarily proceeds through nonhomologous end
joining (NHEJ) and related processes (2). Although NHEJ usually re-
joins the two ends flanking the DSB, under typical genome editing
conditions, DSBs are continuously reintroduced, eventually resulting
in the accumulation of insertions and deletions (indels) or transloca-
tions at the site of the DSB and the disruption of the corresponding ge-
nomic locus (3). Actively dividing cells can also respond to DSBs by
initiating homology-directed repair (HDR) in the presence of a donor
DNAtemplate containinghomology to the regions surrounding theDSB,
which allows researchers to more precisely and predictably manipulate
genomes than is possible through NHEJ (4). HDR-dependent genome
editing is limited by low efficiency arising from competition with NHEJ
outcomes and from the dependence of HDR on mitosis (5).
We recently reported the development of base editing,which enables
the direct, irreversible conversion of a C:G base pair to a T:A base pair in
a programmable manner without requiring HDR or the introduction
of a DSB (6). Base editors consist of a single-stranded DNA (ssDNA)–
specific cytidine deaminase enzyme tethered to a catalytically impaired
Cas9 protein (6–9). The Cas9 variant binds a genomic locus of interest,
programmed by a corresponding guide RNA. Formation of the protein-
RNA-DNAternary “R-loop” complex (10) exposes a small (~5-nucleotide)window of ssDNA that serves as a substrate for the tethered cytidine
deaminase enzyme. Any cytidines within this window are hydrolytically
deaminated to uracils, resulting in G:U intermediates.
Base excision repair (BER) is the cell’s primary response to G:Umis-
matches and is initiated by excision of the uracil by uracil N-glycosylase
(UNG) (11). In an effort to protect the edited G:U intermediate from
excision by UNG, we fused a 83–amino acid uracil glycosylase inhibitor
(UGI) directly to the C terminus of catalytically dead Cas9 (dCas9) (6).
Tomanipulate cellularDNAmismatch repair systems into preferential-
ly replacing the G in the G:U mismatch with an A, we also reverted the
Ala840 amino acid in dCas9 toHis, enabling the Cas9 protein to nick the
DNA strand opposite the newly formed uracil, resulting in much more
efficient conversion of the G:U intermediate to desired A:U and A:T
products (6). Combining these two engineering efforts resulted in
BE3, a single protein consisting of a three-part fusion of the APOBEC1
cytidine deaminase enzyme tethered through a 16–amino acid linker to
Streptococcus pyogenesCas9 nickase [Cas9n(D10A)], which is covalently
linked to UGI through a 4–amino acid linker (6). Since our initial re-
port, the scientific community has used BE3 and related base editors for
a wide variety of applications, including plant genome editing, in vivo
mammalian genome editing, targeted mutagenesis, and knockout
studies (1, 7–9, 12–19). We recently expanded the scope of base editing
by reporting BE3 variants with altered PAM requirements (7), nar-
rowed editing windows (7), reduced off-target editing (9), and small-
molecule dependence (20).
At some loci, base editors such as BE3 give rise to undesired by-
products in which the target C:G base pair is converted into a G:C or
A:Tbase pair, rather than the desiredT:Aproduct (1, 12, 13, 15, 16).Here,
we illuminate determinants of base editing product purity and establish
thatUNGactivity is required for the formation of undesired by-products.
By analyzing individual DNA sequencing reads, we discovered that
blocking UNG access to the uracil intermediate is especially crucial1 of 9
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imize undesired products. Using these insights, we engineered fourth-
generation base editors, BE4 (S. pyogenes Cas9-derived base editor)
and SaBE4 (Staphylococcus aureus Cas9-derived BE4), that perform
base editing with higher efficiency and greatly improved product purity
compared to previously described base editors including BE3. Finally,
we developed additional base editors—BE3-Gam, SaBE3-Gam, BE4-
Gam, and SaBE4-Gam—that use the bacteriophage Mu dsDNA
(double-strandedDNA) end-binding proteinGam tominimize the for-
mation of undesired indels during base editing, and to further increase
product purity with no apparent loss of activity.RESULTS
UNG activity is required for by-product formation
We hypothesized that undesired base editing by-products arise dur-
ing BER because of the formation and error-prone resolution of abasic
sites within the uracil-containing DNA strand. This hypothesis predicts
that the product purity of base editing in cells lacking UNG should be
greatly improved. To test this prediction, we nucleofected HAP1 cells
(a haploidhumancell line) andHAP1UNG− cellswithplasmids encoding
BE3 and single-guide RNAs (sgRNAs) targeting the EMX1, FANCF,
HEK2, HEK3, HEK4, or RNF2 locus (see Fig. 1B for target sequences).
Three days after nucleofection, genomic DNA was extracted, and the
target loci were amplified by polymerase chain reaction (PCR) and ana-
lyzed by high-throughput DNA sequencing (HTS). We define base
editing product purity as the percentage of edited sequencing reads
(reads in which the target C has been converted to a different base) in
which the target C is edited to a T. The base editing product purity of
BE3-treated HAP1 cells averaged 68 ± 6% (means ± SD for n = 3Komor et al., Sci. Adv. 2017;3 : eaao4774 30 August 2017biological replicates) across 12 target C’s in the six loci. Remarkably,
in HAP1 UNG− cells, all 12 target C’s tested were base-edited with
product purities of >98% (Fig. 1C). In addition, indel frequencies at
all six tested loci decreased 7- to 100-fold uponUNGknockout (Fig. 1D).
These data strongly implicate UNG activity as necessary for undesired
product formation during base editing, consistent with a model in
which abasic site formation and subsequent BER with error-prone
polymerases lead to randomization of the target nucleotide and oc-
casional strand breaks that result in indels.
Targets with multiple editable C’s exhibit higher
product purity
Wepreviously reported that base editing efficiency by BE3 can be lower
for some (but not all) target C’s that are immediately downstream of
a G (6), consistent with the known sequence preference of APOBEC1
(Fig. 2B and fig. S2, A and B) (21). In an effort to efficiently edit these
targets, we generated BE3 variants in which we replaced the APOBEC1
deaminase with CDA1 (to generate CDA1-BE3), AID (to generate AID-
BE3), or APOBEC3G (to generate APOBEC3G-BE3), three ssDNA-
specific cytidine deaminase enzymes with different sequence preferences
(22). We transfected human embryonic kidney (HEK) 293T cells with
plasmids encoding these BE3 variants and sgRNAs targeting the EMX1,
FANCF,HEK2,HEK3,HEK4, or RNF2 locus. Three days after transfec-
tion, genomic DNAwas extracted, and the target loci were amplified by
PCR and assessed for base editing using HTS. We observed more effi-
cient editing of target C’s that immediately follow a G with CDA1-BE3
and AID-BE3 than with BE3 (Fig. 2B, fig. S2, and tables S1 to S6). In
general, CDA1-BE3 and AID-BE3 exhibited lower editing efficiencies
than BE3 at target C’s that do not follow a G (fig. S2). In contrast,
APOBEC3G-BE3 exhibited unpredictable sequence preferences, withFig. 1. Effects of knocking outUNG onbase editing product purity. (A) Architecture of BE3. (B) Protospacers and PAM (blue) sequences of the genomic loci tested, with
the target C’s analyzed in (A) shown in red. (C) HAP1 (UNG+) and HAP1 UNG− cells were treated with BE3, as described in Materials and Methods. The product distribution
among edited DNA sequencing reads (reads in which the target C is mutated) is shown. See fig. S1 for C-to-T editing efficiencies, which generally varied between 15 and
45%. (D) Frequency of indel formation following treatment with BE3 in HAP1 or HAP1 UNG− cells. Values and error bars reflect the means and SD of three independent
biological replicates performed on different days. ns (not significant), P ≥ 0.05; *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001, by two-tailed Student’s t test.2 of 9
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suggest that CDA1-BE3 andAID-BE3may offer higher editing efficien-
cies over BE3 for some target 5′-GC-3′ sequences.
While analyzing these data, we noticed that the product purities of
CDA1-BE3 and AID-BE3 were typically higher than those of BE3 at
those sites for which CDA1-BE3 and AID-BE3 edited more C’s than
BE3 (Fig. 2). For example, at theHEK4 locus, BE3 efficiently edits only
a single C (the C not preceded by a G), but both CDA1-BE3 and AID-
BE3 edit three C’s (fig. S2). The product purity of BE3 at this locus is
50 ± 7% (means ± SD for n = 3 biological replicates), whereas the pro-
duct purity of CDA1-BE3 and AID-BE3 are 97 ± 2% and 93 ± 2%,
respectively.Moreover, EMX1 and FANCF, edited by BE3with product
purities of 84 ± 3% and 91 ± 2%, respectively, containmultiple C’s thatKomor et al., Sci. Adv. 2017;3 : eaao4774 30 August 2017are editedwith comparable efficiency (fig. S3), whereasHEK2 andRNF2,
edited byBE3withmuch lower product purities of 28 ± 3%and 64± 3%,
respectively, containmultipleC’s that are editedwithunequal efficiencies
(fig. S3). CDA1-BE3 andAID-BE3,which edit bothC’swithin theHEK2
locus with comparable efficiencies, exhibit much higher product purities
at this locus (85± 5%and 81 ± 4%, respectively) (Fig. 2 and fig. S2C).We
therefore ruled out the possibility that, at theHEK2 and RNF2 sites, the
multiple C’s are initially converted to U’s by BE3 with comparable ef-
ficiency and then processed with different efficiencies by DNA repair
systems; if this were the case, we would expect similar product distribu-
tions when these sites were treatedwith BE3 versus CDA1-BE3 orAID-
BE3, rather than the different product distributions observed (Fig. 2C
and tables S1 to S6). Instead, we hypothesized that an isolated G:UmayFig. 2. Effects ofmulti-C base editing on product purity. (A) Architectures of BE3, CDA1-BE3, and AID-BE3. (B) Representative high-throughput sequencing data of BE3-,
CDA1-BE3–, and AID-BE3–treated human HEK293T cells. The sequence of the protospacer is shown at the top, with the PAM in blue and the target C’s in red, with sub-
scripted numbers indicating their position within the protospacer. Underneath each sequence are the percentages of total sequencing reads with the corresponding base.
The relative percentage of target C’s that are cleanly edited to T rather than to non-T bases aremuch higher for cells treated with AID-BE3, which edits three C’s at this locus,
than for cells treatedwith BE3, which edits only one C. (C) HEK293T cells were treatedwith BE3, CDA1-BE3, and AID-BE3, as described inMaterials andMethods. The product
distribution among edited DNA sequencing reads (reads in which the target C is mutated) is shown. (D) Protospacers and PAM (blue) sequences of genomic loci studied,
with the target C’s analyzed in (B) shown in red. (E) Frequency of indel formation (seeMaterials andMethods) following the treatment in (A). Values and error bars reflect the
means and SD of three independent biological replicates performed on different days. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001, by two-tailed Student’s t test.3 of 9
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tempting to speculate that the processivity of the cytidine deaminase
domain in BE3 (6, 23) may increase the residence time of BE3 at loci
containingmultiple editable C’s, thereby blocking access by UNGmore
effectively than at loci containing a single editable C.
We sought to further probe the relationship between product purity,
the number of edited C’s in individual sequencing reads, and UNG
activity. To reveal the fate of base-edited DNA in the absence of explicit
UNG inhibition, we removed the UGI component of BE3 to generate
BE3B. We transfected HEK293T cells with plasmids encoding BE3 or
BE3B and sgRNAs targeting the EMX1, FANCF, HEK2, HEK3, HEK4,
or RNF2 locus. As expected, given the role of UNG in diversifying base
editing outcomes established above, the product purities at all target C’s
greatly decreased in BE3B-treated DNA compared with BE3-treated
DNA, with the fraction of editing products containing non-Ts increasing
by an average of 1.8 ± 0.4–fold (fig. S4D).
We analyzed individual DNA sequencing reads from HEK293T
cells treated with sgRNAs targeting the multi-C sites HEK2, HEK3,
and RNF2 and either BE3 or BE3B. For each site, we designated the
primary target C as the nucleotide modified most efficiently. Across allKomor et al., Sci. Adv. 2017;3 : eaao4774 30 August 2017three sites, an average of 80± 10%of sequencing reads that contained an
undesired C to non-T edit of the primary target C exhibited only that
single base editing event (figs. S4 and S5). In contrast, across the same
threemulti-C sites, a much lower average of 32 ± 4% of sequencing reads
containing a clean C-to-T edit of the primary target C exhibited only that
single clean base editing event (figs. S4 and S5). In addition, the dis-
tribution of products for BE3B-treatedHEK4DNA, a site that contains
only oneCwithin the editingwindow, roughly follows the ratio of 1:3:1 for
A:G:T (fig. S4E). These observations collectively indicate that when a single
cytidine in a given target is converted toU in the absence of UGI, it is pro-
cessed efficiently by UNG-initiated BER to give a mixture of products.
These data are consistent with a model in which clustered G:Umis-
matches are processed differently than isolatedG:Umismatches and are
more likely to produce clean C-to-T edits. When only a single C-to-T
editing event is desired, the abovementioned observations suggest that
UNG inhibition is critical to minimize undesired by-products. However,
when performing targeted randommutagenesis using dCas9-deaminase
fusions, such aswithTAM(16) andCRISPR-X (12), the abovementioned
observations suggest that using BE3B on target sites with a minimum
number of editable C’s will maximize product mixtures.Fig. 3. Effects of changing the architecture of BE3 on C-to-T editing efficiencies and product purities. (A) Architectures of BE3, SSB-BE3, N-UGI-BE3, and BE3-2xUGI.
(B) Protospacers and PAM (blue) sequences of genomic loci studied, with the target C’s in (C) shown in purple and red, and the target C’s in (B) shown in red. (C) HEK293T
cells were treated with BE3, SSB-BE3, N-UGI-BE3, and BE3-2xUGI, as described in Materials and Methods. The product distribution among edited DNA sequencing reads
(reads in which the target C is mutated) is shown for BE3, N-UGI-BE3, and BE3-2xUGI. (D) C-to-T base editing efficiencies. Values and error bars reflect the means and SD of
three independent biological replicates performed on different days. ns, P ≥ 0.05; *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001, by two-tailed Student’s t test.4 of 9
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We sought to improve the product purity of base editing, especially for
sites with a single C or with unevenly edited C’s. The abovementioned
findings suggest that optimizing BE3 to minimize access of UNG to
the G:U intermediate should improve product purity. We first tried re-
placing the UGI component of BE3 with an ssDNAbinding protein to
yield SSB-BE3, reasoning that SSB may block the uracil-containing
ssDNA portion of the R-loop from being accessed by UNG. We ob-
served large decreases in base editing efficiency by SSB-BE3, with all
seven C’s across the four sites exhibiting an average of only 1.9 ± 0.5%
C-to-T conversion (Fig. 3D). These data suggest that although the
tethered deaminase enzyme is present at elevated effective molarity,
SSB protects the ssDNA portion of the R-loop from the deaminase en-
zyme, impeding base editing.
Because the relative positioning of APOBEC,UGI, andUNGduring
steps that determine base editing outcomes is not known, we moved
UGI to the N terminus of BE3 (N-UGI-BE3) in an effort to improve
UNG inhibition. Moving UGI to the N terminus of BE3 resulted in
an average decrease in C-to-T editing percentages of 2.3 ± 0.6–fold
across all seven tested target C’s compared to BE3 (Fig. 3D) and a de-
crease in overall product purity averaging 2.2 ± 0.5–fold at all four sites
compared to BE3 (Fig. 3C). We concluded that the N-UGI-BE3
architecture is suboptimal for deaminase activity and may also impede
UNG inhibition by UGI.
In contrast, appending an additional copy of UGI to the C terminus
of BE3 (BE3-2xUGI) resulted in large increases in product purities re-
lative to BE3 and C-to-T editing percentages comparable to those ofKomor et al., Sci. Adv. 2017;3 : eaao4774 30 August 2017BE3. Non-T editing products decreased by an average of 2.2 ± 0.8–fold
across the four loci tested (Fig. 3C). These observations suggest that
addition of a second copy of UGI substantially decreases the access of
UNG to the G:U base editing intermediate, thereby greatly improving
product purity.
Because these experiments revealed the sensitivity of base editing out-
comes to the architecture of the components, we next optimized the
linkers between BE3 components to further increase product purities
and editing efficiencies. We varied the rAPOBEC1-Cas9n(D10A)
linker from 16 amino acids (BE3) to 32 amino acids (BE3C) and the
Cas9n(D10A)-UGI linker from 4 (BE3) to 9 (BE3D) to 16 amino acids
(BE3E) (Fig. 4A). Non-T product formation on average decreased 1.3 ±
0.1–fold when the Cas9n(D10A)-UGI linker was nine amino acid resi-
dues in length (BE3D) instead of four amino acids (BE3) (Fig. 4D),
with no apparent differences in C-to-T editing efficiencies (Fig. 4C).
Increasing the rAPOBEC1-Cas9n(D10A) linker from 16 amino acids
(BE3) to 32 amino acids (BE3C) elevated C-to-T editing efficiencies an
average of 1.2 ± 0.1–fold at the HEK2 locus (Fig. 4C). This locus was
previously the most unevenly edited multi-C site tested (fig. S3), and
extending this linker led to a reduction in preferential editing of C6
over C4 (the ratio of the percentage of sequencing reads that are edited
at C6 to that of C4) from 2.6 ± 0.2–fold to 1.8 ± 0.1–fold. We reasoned
that this longer linker may allow the deaminase better access to the
ssDNA in the R-loop and result in more uniform deamination when
multiple target C’s are present in the base editing window. BE3C also
exhibited comparable or improved base editing efficiencies and product
purities at the other loci tested (Fig. 4, C and D).Fig. 4. Effects of linker length variation in BE3 on C-to-T editing efficiencies and product purities. (A) Architecture of BE3, BE3C, BE3D, and BE3E. (B) Protospacers
and PAM (blue) sequences of genomic loci studied, with the target C’s in (C) shown in purple and red, and target C’s in (D) shown in red. (C) HEK293T cells were treated
with BE3, BE3C, BE3D, or BE3E, as described in Materials and Methods. C-to-T base editing efficiencies are shown. (D) The product distribution among edited DNA
sequencing reads (reads in which the target C is mutated) is shown for BE3, BE3C, BE3D, and BE3E. Values and error bars reflect the means and SD of three independent
biological replicates performed on different days. ns, P ≥ 0.05; *P < 0.05; **P < 0.01, by two-tailed Student’s t test.5 of 9
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efficiency and product purity
We combined all three improvements—extending the rAPOBEC1-
Cas9n linker to 32 amino acids, extending the Cas9n-UGI linker to
9 amino acids, and appending a second copy of UGI to the C terminus
of the construct with another 9–amino acid linker—into a single base
editor construct, BE4. We also cloned Target-AID, an alternative base
editor construct reported by Nishida et al. (8), into the same plasmid
backbone as BE4. We transfected HEK293T cells with plasmids en-
coding BE3, BE4, or Target-AID and sgRNAs targeting the EMX1,
FANCF,HEK2,HEK3,HEK4, or RNF2 locus. Three days after transfec-
tion, genomic DNAwas extracted, and the target loci were amplified by
PCR and analyzed by HTS.We observed an average increase in C-to-T
editing efficiencies of 1.5 ± 0.3–fold across all 12 edited C’s for BE4 re-
lative to BE3 (Fig. 5C).Although the average efficiency of C-to-T editing
for Target-AID at the same positions analyzed was 1.5 ± 0.5–fold lower
than that of BE3 and 2.1 ± 0.5–fold lower than that of BE4, it is impor-
tant to note that Target-AID, which uses the CDA1 deaminase, appears
to have an editingwindow shifted relative to BE3 and BE4, with optimal
editing around positions C3 and C4 (Fig. 5C). This shifted editing
window makes comparisons of efficiency and product purity between
Target-AID and BE3 or BE4 difficult because a given target C could lie
in more optimal or less optimal position within the different editing
windows, even when using the same guide RNA.
In addition to greater C-to-T editing efficiency, BE4 also exhibited
substantially improved product purities relative to BE3 at all genomicKomor et al., Sci. Adv. 2017;3 : eaao4774 30 August 2017loci tested, with an average decrease in non-T product formation of
2.3 ± 0.3–fold (Fig. 5D). As expected from further impeding BER,which
can lead to indels (24), we also observed decreases in indel rates aver-
aging 2.3 ± 1.1–fold across all six loci following BE4 treatment com-
pared to BE3 (fig. S6A). Together, these results indicate that BE4 offers
higher efficiencies of C-to-T editing, higher product purities, and lower
indel rates than BE3 at all loci tested.
We tested whether the BE4 improvements could be integrated with
S. aureus Cas9 (25) to generate SaBE4, which replaces the S. pyogenes
Cas9n(D10A) with the smaller S. aureus Cas9n(D10A) and can access
different targets because of its alternative PAM requirements.We trans-
fected HEK293T cells with plasmids encoding SaBE3 (7) or SaBE4 and
sgRNAs targeting the FANCF, HEK3, or HEK4 locus. Consistent with
the results comparing BE4 and BE3, we observed an average increase in
C-to-T editing efficiencies of 1.4 ± 0.2–fold across all 10 edited C’s for
SaBE4 relative to SaBE3 (fig. S7A), with a 1.8 ± 0.5–fold average de-
crease in undesired non-T editing products (fig. S7C). These results in-
dicate that the gains in base editing efficiency and product purity that
arise from the BE4 enhancements also apply to base editors derived
from other Cas9 homologs.
Fusion with Gam further reduces indel frequencies and
improves product purity
For some genome editing applications, the formation of indels con-
founds research or poses safety risks. We therefore sought to further
decrease indel frequencies that arise frombase editing.WehypothesizedFig. 5. BE4 increases base editing efficiency and product purities compared to BE3. (A) Architectures of BE3, BE4, and Target-AID. (B) Protospacers and PAM (blue)
sequences of genomic loci studied, with the target C’s in (C) shown in purple and red, and the target C’s in (D) shown in red. (C) HEK293T cells were treated with BE3, BE4, or
Target-AID, as described in Materials and Methods. C-to-T base editing efficiencies are shown. (D) The product distribution among edited DNA sequencing reads (reads in
which the target C is mutated) is shown for BE3 and BE4. Values and error bars reflect the means and SD of three independent biological replicates performed on different
days. ns, P ≥ 0.05; *P < 0.05; **P < 0.01, by two-tailed Student’s t test.6 of 9
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DNA-(apurinic or apyrimidinic site) lyase (AP lyase), a BER enzyme
that converts abasic sites into ssDNA nicks (24). Because base editors
nick the strand opposite the U, cleavage of the glycosidic bond by UNG
followed by processing of the resulting AP site by AP lyase would result
in a DSB, which promotes indel formation. This model is consistent
with our observation of greatly reduced indel frequencies in UNG
knockout cells (Fig. 1D). The Gam protein of bacteriophage Mu binds
to the ends of DSBs and protects them from degradation (26), and has
been repurposed to image DSBs in live mammalian cells (27). We rea-
soned that using Gam to bind the free ends of DSB may reduce indel
formation during the process of base editing. We therefore fused the
174-residue Gam protein to the N terminus of BE3, SaBE3, BE4, and
SaBE4 via the 16–amino acid XTEN linker to generate BE3-Gam,
SaBE3-Gam, BE4-Gam, and SaBE4-Gam, respectively.
BE3-Gam and SaBE3-Gam decreased indel frequencies relative to
BE3 and SaBE3 at all six and four genomic loci tested by an average
of 1.7 ± 0.3–fold and 2.0 ± 1.0–fold, respectively (Fig. 6C and fig.
S7D). C-to-T editing efficiencies for BE3-Gam and SaBE3-Gamwere
similar to those of BE3 and SaBE3, respectively (Fig. 6B). In addition,
BE3-Gam and SaBE3-Gam also exhibited increased product purity
relative to BE3 and SaBE3 at all genomic loci tested, with an average
decrease in non-T product formation of 1.5 ± 0.1–fold and 2.3 ±
0.6–fold, respectively (Fig. 6D).
BE4-Gam exhibited greatly decreased indel frequencies relative to
BE4, with an average decrease of 2.1 ± 0.9–fold (Fig. 6C). In general,Komor et al., Sci. Adv. 2017;3 : eaao4774 30 August 2017indel frequency following BE4-Gam treatment is below 1.5%. Com-
pared to SaBE4, SaBE4-Gam exhibited an average decrease in indel
formation of 1.5 ± 0.8–fold (fig. S7D). We observed no apparent de-
creases in C-to-T editing efficiencies for BE4-Gam or SaBE4-Gam rel-
ative to BE4 and SaBE4, respectively (Fig. 6B), BE4-Gam offers overall
editing/indel ratios that increase an average of 2.0 ± 1.1–fold across
all six sites relative to BE4 (fig. S6B). Product purities of BE4-Gam are
improved compared with BE4, with an average decrease in non-T prod-
uct formation of 2.1 ± 0.7–fold (Fig. 6D).
Similarly, SaBE4-Gam exhibited an average decrease in non-T
product formation of 1.7 ± 0.5–fold relative to SaBE4, with no apparent
decrease in C-to-T editing efficiencies (Fig. 6). These data suggest that
for sites that can be targeted by S. aureus Cas9, SaBE4-Gam provides the
best combination of high C-to-T base editing efficiency, reduced indel for-
mation, and increased product purity. Together, the abovementioned find-
ings establish that the fusion of bacteriophageMuGamprotein to decrease
indel formation is compatible with multiple genome editing agents.
DISCUSSION
For base editing applications in which minimizing indel production is
critical and Gam binding of DSBs is acceptable, BE4-Gam or SaBE4-
Gam may be preferred BE4-Gam variants offer the lowest indel fre-
quency and highest product purity among the base editors tested in
this study. C-to-T editing efficiency/indel ratios increase as BE3 <
BE3-Gam < BE4 < BE4-Gam across all six genomic loci (fig. S6B).
We speculate that Gam may be inducing the death of DSB-containingFig. 6. Fusionwith Gam frombacteriophageMu reduces indel frequencies. (A) Architectures of BE3-Gam and BE4-Gam. (B) HEK293T cells were treated with BE3, BE3-Gam,
BE4, BE4-Gam, SaBE3, SaBE3-Gam, SaBE4, or SaBE4-Gam, as described in Materials andMethods. C-to-T base editing efficiencies are shown. (C) Frequency of indel formation (see
Materials and Methods) following the treatment in (B). (D) Product distribution among edited DNA sequencing reads (reads in which the target C is mutated). (E) Protospacers
and PAM (blue) sequences of genomic loci studied, with the target Cs in (B) shown in purple and red, and the target Cs in (D) shown in red. Values and error bars of BE3-Gam,
SaBE3-Gam, BE4-Gam, and SaBE4-Gam reflect the means and SD of three independent biological replicates performed on different days. Values and error bars of BE3, SaBE3,
BE4, and SaBE4 reflect the means and SD of six independent biological replicates performed on different days by two different researchers. ns, P ≥ 0.05; *P < 0.05; **P < 0.01; ***P <
0.001; ****P < 0.0001, by two-tailed Student’s t test.7 of 9
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from the population of treated, surviving cells.
Collectively, these developments advance the state of the art in
programmable C:G to T:A base pair conversion and thereby increase
the utility and applicability of base editing. Our findings also suggest
that Gam has the potential to be repurposed to minimize indel forma-
tion in other genome editing applications. Finally, relationships among
uracil incorporation, UNG activity, and cellular DNA repair outcomes
illuminated in this study may guide future efforts to understand or
manipulate eukaryotic DNA repair.MATERIALS AND METHODS
Cloning of plasmids
All plasmids in this study were generated by USER cloning using
Phusion U Hot Start Polymerase (Thermo Fisher). Deaminase and
SSB genes were synthesized as gBlocks Gene Fragments (Integrated
DNATechnologies), andTarget-AIDwasobtained fromAddgene (plasmid
#79620). Protein sequences are listed in Supplementary Sequences.
Cell culture
HEK293T (American Type Culture Collection CRL-3216) cells were
maintained in Dulbecco’s modified Eagle’s medium plus GlutaMAX
(Thermo Fisher) supplemented with 10% (v/v) fetal bovine serum
(FBS) at 37°C with 5% CO2. HAP1 (Horizon Discovery C631) and
HAP1 UNG− (Horizon Discovery HZGHC001531c012) were main-
tained in Iscove’s modified Dulbecco’s medium plus GlutaMAX
(Thermo Fisher Scientific) supplemented with 10% (v/v) FBS at 37°C
with 5% CO2.
Transfections
HEK293T cells were seeded on 48-well collagen-coated BioCoat plates
(Corning) and transfected at approximately 75% confluency. Briefly,
750 ng of BE and 250 ng of sgRNA expression plasmids were trans-
fected using 1.5 ml of Lipofectamine 2000 (Thermo Fisher Scientific)
per well according to the manufacturer’s protocol.
HAP1 and HAP1 UNG− cells were nucleofected using the SE Cell
Line 4D-Nucleofector X Kit S (Lonza) according to the manufacturer’s
protocol. Briefly, 4 × 105 cells were nucleofected with 300 ng of BE and
100 ng of sgRNA expression plasmids using the 4D-Nucleofector
program DZ-113.
HTS of genomic DNA samples
Transfected cells were harvested after 3 days, and the genomic DNA
was isolated by incubating cells in lysis buffer [10 mM tris-HCl
(pH 8.0), 0.05% SDS, proteinase K (25 mg/ml)] at 37°C for 1 hour fol-
lowed by 80°C for 30 min. Genomic regions of interest were amplified
by PCR with flanking HTS primer pairs, as previously described (6, 7).
PCR amplification was carried out with Phusion High-Fidelity DNA
Polymerase (Thermo Fisher), according to the manufacturer’s instruc-
tions and as previously described. Purified DNAwas amplified by PCR
with primers containing sequencing adaptors. The products were gel-
purified and quantified using the Quant-iT PicoGreen dsDNA Assay Kit
(ThermoFisher) andKAPALibraryQuantificationKit (KAPABiosystems).
Samples were sequenced on an IlluminaMiSeq, as previously described.
Data analysis
Sequencing readswere automatically demultiplexedusingMiSeqReporter
(Illumina), and individual FASTQ files were analyzed with a customKomor et al., Sci. Adv. 2017;3 : eaao4774 30 August 2017MATLAB script, as previously described (6). Each read was pairwise-
aligned to the appropriate reference sequence using the Smith-Waterman
algorithm. Base calls with a Q-score below 31 were replaced with N’s
andwere thus excluded in calculating nucleotide frequencies. This treat-
ment yields an expected MiSeq base-calling error rate of approximately
1 in 1000. Aligned sequences in which the read and reference sequence
contained no gaps were stored in an alignment table from which base
frequencies could be tabulated for each locus.
Indel frequencies were quantified with the previously described
MATLAB script (6, 7, 9). Briefly, sequencing reads were scanned for
exact matches to two 10–base pair (bp) sequences that flank both sides
of a window in which indels might occur. If no exact matches were lo-
cated, the read was excluded from the analysis. If the length of this indel
window exactly matched the reference sequence, the read was classified
as not containing an indel. If the indel window was two or more bases
longer or shorter than the reference sequence, then the sequencing read
was classified as an insertion or deletion, respectively.
To evaluate interdependency (linkage disequilibrium) between the
base editing outcomes at the multiple target cytidines within an editing
window, target site sequences from BE-treated cells were analyzed by a
custom Python script (note S1). Briefly, sequencing reads were scanned
for exactmatches to two7-bp sequences that flank each side of the proto-
spacer. If the intervening region was not exactly 20 bp, then it was ex-
cluded from further analysis. The protospacer sequences were further
filtered into four groups based on the identity of the nucleotide at the
position with the most non-T editing outcomes (the primary target C).
For each of these four groups as well as the entire pool, we tallied the
nucleotide abundance at each of the 20 positions within the protospacer.SUPPLEMENTARY MATERIALS
Supplementary material for this article is available at http://advances.sciencemag.org/cgi/
content/full/3/8/eaao4774/DC1
fig. S1. Base editing efficiencies in UNG knockout cells.
fig. S2. CDA1-BE3 and AID-BE3 edit C’s following target G’s more efficiently than BE3.
fig. S3. Uneven editing in sites with multiple editable C’s results in lower product purity.
fig. S4. Base editing of multiple C’s results in higher base editing product purity.
fig. S5. Base editing of multiple C’s results in higher base editing product purity at the HEK3
and RNF2 loci.
fig. S6. BE4 induces lower indel frequencies than BE3, and Target-AID exhibits similar product
purities as CDA1-BE3.
fig. S7. SaBE4 exhibits increased base editing yields and product purities compared to SaBE3.
table S1. Base editing outcomes from treatment with BE3, CDA1-BE3, AID-BE3, or APOBEC3G-
BE3 at the EMX1 locus.
table S2. Base editing outcomes from treatment with BE3, CDA1-BE3, AID-BE3, or APOBEC3G-
BE3 at the FANCF locus.
table S3. Base editing outcomes from treatment with BE3, CDA1-BE3, AID-BE3, or APOBEC3G-
BE3 at the HEK2 locus.
table S4. Base editing outcomes from treatment with BE3, CDA1-BE3, AID-BE3, or APOBEC3G-
BE3 at the HEK3 locus.
table S5. Base editing outcomes from treatment with BE3, CDA1-BE3, AID-BE3, or APOBEC3G-
BE3 at the HEK4 locus.
table S6. Base editing outcomes from treatment with BE3, CDA1-BE3, AID-BE3, or APOBEC3G-
BE3 at the RNF2 locus.
note S1. Python script to detect linkage disequilibrium in base editing outcomes at target sites
with multiple target cytidines.
Supplementary Sequences. Amino acid sequences of CDA1-BE3, AID-BE3, BE3-Gam, SaBE3-
Gam BE4, BE4-Gam, SaBE4, and SaBE4-Gam.REFERENCES AND NOTES
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